We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors (SPICE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02636036
Recruitment Status : Completed
First Posted : December 21, 2015
Last Update Posted : November 9, 2021
Bristol-Myers Squibb
Syneos Health
Information provided by (Responsible Party):
PsiOxus Therapeutics Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 8, 2021
Actual Study Completion Date : October 8, 2021